Pamela Pegman is a seasoned biologics R&D executive with over 20 years of experience in CMC and drug substance strategy and program management. Currently serving as Head of Business Development and Licensing in Pharmaceutical Science at Takeda, Pamela has previously held key roles at companies like Pfizer, Amgen, GlaxoSmithKline, and Eleven Biotherapeutics, where they focused on bioprocess development, regulatory engagement, and cross-functional team leadership. Pamela is pursuing a PhD in Biotechnology with a focus on molecular/cellular biology, building on an earlier BSc in Biotechnology from Dublin City University. Their expertise in managing global teams and aligning R&D with business priorities has consistently driven clinical-stage program success.
This person is not in the org chart
This person is not in any teams
This person is not in any offices